Taxanes-induced peripheral neuropathy. Drug-induced polyneuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with breast, gynecological and urology cancer in the age range of 18-80 years with complaints of peripheral neuropathy symptoms, according to the opinion of a neurologist; their neuropathy is due to chemotherapy with taxane drugs. Are undergoing chemotherapy or have a history of chemotherapy, provided that no more than two months have passed since the completion of their chemotherapy, regardless of the number of chemotherapy courses.
Exclusion criteria
Exclusion criteria: Having diabetes and other neuropathies such as Guillain-Barré, multiple sclerosis, and carpal tunnel syndrome Allergy to herbal medicines Stage 4 cancer patients Patients who perform radiotherapy at the same time as chemotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensory and motor disorders and pain and symptoms of neuropathy in the lower and upper limbs. Timepoint: The beginning of the study (before the start of the intervention) and 28 days after the start of topical herbal oil consumption (the end of the intervention). Method of measurement: To quantitatively evaluate peripheral neuropathy before and after intervention(Questionnaire FACT/GOG-Ntx Version 4)Functional Assessment of Cancer Therapy for patients with neurotoxicity questionnaire - version 4 (FACT-GOG-NTX), Qualitative symptoms of peripheral neuropathy based on the scalePNQ (Patient Neurotoxicity Questionnaire), Pain before and after the intervention; Neuropathic Pain Scale (NPS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Registration of possible complications. Timepoint: While studying. Method of measurement: Side effects registration form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mazandaran University of Medical Sciences